−0.4695 EUR
−1.57 M EUR
117.84 K EUR
About THERAVET
Sector
CEO
Enrico Jose Adolfo Bastianelli
Website
Headquarters
Gosselies
Founded
2017
ISIN
BE0974387194
FIGI
BBG01175J220
TheraVet SA is a veterinary biotech company, which specializes in the development and production of treatments for osteoarticular diseases in cats, dogs, and horses. Its products include Biocera-Vet and Visco-Vet. The company was founded by Enrico Jose Adolfo Bastianelli on November 21, 2017 and is headquartered in Gosselies, Belgium.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of ALVET is 0.1085 EUR — it has increased by 2.36% in the past 24 hours. Watch THERAVET stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on EURONEXT exchange THERAVET stocks are traded under the ticker ALVET.
ALVET stock has risen by 0.93% compared to the previous week, the month change is a 38.75% rise, over the last year THERAVET has showed a −92.52% decrease.
ALVET reached its all-time high on Jun 21, 2021 with the price of 8.5600 EUR, and its all-time low was 0.0630 EUR and was reached on Nov 26, 2024. View more price dynamics on ALVET chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
ALVET stock is 15.79% volatile and has beta coefficient of 0.93. Track THERAVET stock price on the chart and check out the list of the most volatile stocks — is THERAVET there?
Yes, you can track THERAVET financials in yearly and quarterly reports right on TradingView.
ALVET net income for the last half-year is −848.70 K EUR, while the previous report showed −665.55 K EUR of net income which accounts for −27.52% change. Track more THERAVET financial stats to get the full picture.
No, ALVET doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 26, 2024, the company has 7.00 employees. See our rating of the largest employees — is THERAVET on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. THERAVET EBITDA is −1.30 M EUR, and current EBITDA margin is −942.90%. See more stats in THERAVET financial statements.
Like other stocks, ALVET shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade THERAVET stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So THERAVET technincal analysis shows the buy rating today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating THERAVET stock shows the sell signal. See more of THERAVET technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.